跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kombiglyze XR - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Kombiglyze XR
Approved
STANDARD
Kombiglyze XR
AstraZeneca Pharmaceuticals, LP
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a7da62c114707af6
Company
AstraZeneca Pharmaceuticals, LP
Type
Standard
Approval Details
Approval Id
a7da62c114707af6
Drug Approval Philippines Name
Kombiglyze XR
Product Name
Kombiglyze XR
Registration Number
DR-XY40720
Brand Name
Kombiglyze XR
Generic Name
Saxagliptin (as Hydrochloride) + Metformin Hydrochloride (in extended release form)
Dosage Form
Film-Coated Tablet
Dosage Strength
2.5mg/ 1g
Manufacturer
AstraZeneca Pharmaceuticals, LP
Trader
AstraZeneca UK Limited
Importer
AstraZeneca Pharmaceuticals (Phils.), Inc.
Trader Detail Path
/organization/astrazeneca-uk-limited
Issuance Date
28 December 2021
Expiry Date
05 March 2027
Pharmacologic Category
Combination of Oral Blood Glucose Lowering Drugs
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a7da62c114707af6
Type
Standard
Back to Philippines FDA Approvals